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ABSTRACT 
A reliable biomarker has not been identified to predict the outcome of traumatic brain injury (TBI) in children. 
Therefore, the present systematic review and meta-analysis aimed to assess the association between neuron spe-
cific enolase (NSE) and traumatic brain injury (TBI) in children. Two independent reviewers searched electronic 
databases of EMBASE, Cochrane library, Medline and Scopus and then they summarized the results and did a 
quality control check. At the end, standardized mean difference (SMD) with 95 % confidence interval (CI) and 
performance of NSE were assessed. 10 studies were included in the present meta-analysis. Average serum 
(SMD=1.3; 95 % CI: 0.5 to 2.1; p=0.001) and CSF levels (SMD=2.45; 95 % CI: 1.04 to 3.8; p<0.0001) of NSE 
biomarker were significantly higher in children with TBI with unfavorable outcome compared with other children. 
Serum NSE had an area under the curve, sensitivity and specificity of 0.75 (95 % CI: 0.72 to 0.79), 0.74 (95 % CI: 
0.64 to 0.82) and 0.69 (95 % CI: 0.59 to 0.77), respectively in prediction outcome of TBI. Positive likelihood ratio, 
negative likelihood ratio and diagnostic odds ratio of serum NSE were 2.4 (95 % CI: 1.7 to 3.3), 0.38 (95 % CI: 
0.26 to 0.55) and 6.0 (95 % CI: 3.0 to 12.0), respectively. The results show that the performance of NSE is in a 
moderate level in prediction of unfavorable outcome in children with TBI. However, data in this aspect is not 
sufficient and more studies are needed. 
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INTRODUCTION 
Traumatic brain injuries (TBI) comprise 
2.8 million emergency department visits, hos-
pitalizations, and deaths annually. These 
amounts are even more than annual incidence 
of other neurodegenerative disorders com-
bined (Taylor et al., 2017). TBI is the most 
important cause of mortality and morbidity 
among children and these morbidities consist 
of a wide spectrum from transient to persis-
tent injuries (Thurman, 2016). Studies show 
that early identification of high risk patients 
with TBI leads to reduction in disease burden, 
mortality and morbidity of these injuries. 
However, reliable criteria have not been de-
veloped yet for prediction of the presence of 
brain lesions in patients with head trauma, es-
pecially children (Dayan et al., 2017; DeFazio 
et al., 2014). Therefore, researchers are 
searching for an ideal marker which has high 
accuracy and validity for prediction of brain 
injury, rises only after brain injury, rises rap-
idly in serum and has a time association with 
the beginning of trauma (Wilkinson et al., 
2016). The presence of such a marker gives 
physicians an opportunity to follow patients 
with head trauma without neurologic signs 
more accurately. 
There is a cascade of molecular, cellular 
and biochemical changes after TBI which 
worsens traumatic brain injury in children. 
Therefore, the severity of head injury is more 
accurately assessed by following molecules, 
peptides and biomarkers released as result of 
these changes. Neuron specific enolase (NSE) 
is one of these neuropeptides (Rodríguez-
Rodríguez et al., 2016). NSE is a 75 kilodal-
ton gama homodimer specific for neurons and 
neuroendocrine tissue (Haque et al., 2016; Shi 
et al., 2017). Its level is not considerable in 
other tissue. As this protein is specific to neu-
ral tissue, its serum or CSF level more com-
monly rises in case of neural tissue injury or 
disease. Its serum and CSF level rises in early 
hours after trauma and therefore its measure-
ment can be helpful in identifying TBI. In the 
past decade, NSE was primarily considered as 
a peripheral biomarker of permeability of the 
blood brain barrier. For example, Rodríguez-
Rodrígue et al. (2016) showed elevated levels 
of this protein indicate the presence of a TBI. 
Papa et al. (2015) showed that elevated level 
of NSE in traumatic patients is a possible 
screening tool for diagnosing inflicted TBI. 
Therefore, using this marker may be an accu-
rate and sensitive tool for assessing brain in-
jury in a molecular level before occurrence of 
extensive injuries. A meta-analysis by Cheng 
et al. (2014) showed that serum level of this 
protein rises significantly in adult patients 
with moderate to severe traumatic injuries and 
can be used as a tool for assessing the severity 
of brain injury. Mercier et al. (2016) reached 
similar results. However, using NSE for iden-
tification of traumatic brain injury in children 
is controversial. A consensus has not been 
reached yet in the field of pediatrics. There-
fore, the present systematic review and meta-
analysis aimed to assess the association be-
tween NSE and traumatic brain injury in chil-
dren. 
 
MATERIALS AND METHODS 
Search strategy 
The present study was designed based on 
instructions on Meta-analysis of Observa-
tional Studies in Epidemiology (MOOSE) 
statement (Stroup et al., 2000). Two inde-
pendent reviewers searched electronic data-
bases of EMBASE, Cochrane library, Med-
line and Scopus without a time limit. The 
search strategy was based on words related to 
traumatic brain injury and protein biomarkers 
emphasizing on NSE protein. Keywords were 
obtained using MeSH (Medical Subject 
Headings) in PubMed database and Emtree in 
Embase database. Additionally, in order to 
find additional articles and unprinted data, a 
hand-search was done in the bibliography of 
relevant studies, Google Scholar, Google mo-
tor engine, ProQuest and Trip database. Key-
words used in the search are shown in Table 
1. 
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Table 1: Search queries in Medline, Embase and Scopus databases 
Database Query 
Medline (“Brain Injuries”[mesh] OR “Brain Injuries”[tiab] OR “Head Injuries”[tiab] OR “Brain In-
jury”[tiab] OR “Injury, Brain”[tiab] OR “Injuries, Brain”[tiab] OR “Brain Injuries, Dif-
fuse”[tiab] OR “Brain Injury, Diffuse”[tiab] OR “Diffuse Brain Injuries”[tiab] OR “Diffuse 
Brain Injury”[tiab] OR “Injuries, Diffuse Brain”[tiab] OR “Injury, Diffuse Brain”[tiab] OR 
“Brain Injuries, Focal”[tiab] OR “Brain Injury, Focal”[tiab] OR “Focal Brain Injury”[tiab] 
OR “Injuries, Focal Brain”[tiab] OR “Injury, Focal Brain”[tiab] OR “Focal Brain Inju-
ries”[tiab] OR “Brain Injuries, Traumatic”[tiab] OR “Brain Injury, Traumatic”[tiab] OR 
“Injuries, Traumatic Brain”[tiab] OR “Injury, Traumatic Brain”[tiab] OR “Traumatic 
Brain Injuries”[tiab] OR “Injury, Brain, Traumatic”[tiab] OR “Traumatic Encephalopa-
thy”[tiab] OR “Trauma, Brain”[tiab] OR “Brain Trauma”[tiab] OR “Brain Traumas”[tiab] 
OR “Traumas, Brain”[tiab] OR “Traumatic Brain Injury”[tiab] OR “Encephalopathy, 
Traumatic”[tiab] OR “Encephalopathies, Traumatic”[tiab] OR “Traumatic Encephalo-
pathies”[tiab] OR “TBI (Traumatic Brain Injury)”[tiab] OR “TBIs (Traumatic Brain In-
jury)”[tiab] OR “Brain Lacerations”[tiab] OR “Brain Laceration”[tiab] OR “Laceration, 
Brain”[tiab] OR “Lacerations, Brain”[tiab] OR “Brain Contusion”[tiab] OR “Brain Contu-
sions”[tiab] OR “Contusion, Brain”[tiab] OR “Contusions, Brain”[tiab] OR “Cortical 
Contusion”[tiab] OR “Contusion, Cortical”[tiab] OR “Contusions, Cortical”[tiab] OR 
“Cortical Contusions”[tiab] OR “Encephalopathy, Post-Concussive”[tiab] OR “Enceph-
alopathies, Post-Concussive”[tiab] OR “Encephalopathy, Post Concussive”[tiab] OR 
“Post-Concussive Encephalopathies”[tiab] OR “Post-Concussive Encephalopa-
thy”[tiab] OR “Post Concussive Encephalopathy”[tiab] OR “Encephalopathy, Post-
Traumatic”[tiab] OR “Encephalopathies, Post-Traumatic”[tiab] OR “Encephalopathy, 
Post Traumatic”[tiab] OR “Post-Traumatic Encephalopathies”[tiab] OR “Post-Trau-
matic Encephalopathy”[tiab] OR “Post Traumatic Encephalopathy”[tiab] OR “Injuries, 
Acute Brain”[tiab] OR “Acute Brain Injury”[tiab] OR “Brain Injury, Acute”[tiab] OR “In-
jury, Acute Brain”[tiab] OR “Acute Brain Injuries”[tiab] OR “Brain Injuries, Acute”[tiab] 
OR “Mild Traumatic Brain Injury”[tiab] OR “Injury, Brain, Traumatic Mild”[tiab]) AND 
(“Phosphopyruvate Hydratase”[mesh]” OR “Hydratase, Phosphopyruvate”[tiab] OR 
“2-Phospho-D-Glycerate Hydrolase”[tiab] OR “2 Phospho D Glycerate Hydro-
lase”[tiab] OR “Enolase”[tiab] OR “2-Phospho-D-Glycerate Hydro-Lyase”[tiab] OR “2 
Phospho D Glycerate Hydro Lyase”[tiab] OR “Hydro-Lyase, 2-Phospho-D-Glycer-
ate”[tiab] OR “2-Phosphoglycerate Dehydratase”[tiab] OR “2 Phosphoglycerate Dehy-
dratase”[tiab] OR “Dehydratase, 2-Phosphoglycerate”[tiab] OR “beta-Enolase”[tiab] 
OR “beta Enolase”[tiab] OR “Muscle-Specific Enolase”[tiab] OR “Enolase, Muscle-
Specific”[tiab] OR “Muscle Specific Enolase”[tiab] OR “Enolase 3”[tiab] OR “alpha-
Enolase”[tiab] OR “alpha Enolase”[tiab] OR “Non-Neuronal Enolase”[tiab] OR “Eno-
lase, Non-Neuronal”[tiab] OR “Non Neuronal Enolase”[tiab] OR “gamma-Eno-
lase”[tiab] OR “gamma Enolase”[tiab] OR “Nervous System-Specific Enolase”[tiab] 
OR “Enolase, Nervous System-Specific”[tiab] OR “Nervous System Specific Eno-
lase”[tiab] OR “System-Specific Enolase, Nervous”[tiab] OR “Neuron-Specific Eno-
lase”[tiab] OR “Enolase, Neuron-Specific”[tiab] OR “Neuron Specific Enolase”[tiab] 
OR “Enolase 2”[tiab]) 
 
Embase 'brain injury':ab,ti OR 'brain injury acute':ab,ti OR (head:ab,ti AND trauma:ab,ti) OR 
(traumatic:ab,ti AND brain:ab,ti AND injury:ab,ti) OR (post:ab,ti AND traumatic:ab,ti 
AND encephalopathy:ab,ti) 
 
'neuron specific enolase':ab,ti OR 'enolase':ab,ti OR (phosphopyruvate:ab,ti AND hy-
dratase:ab,ti) OR (nervous:ab,ti AND 'system specific':ab,ti AND enolase:ab,ti) OR 
'enolase 2':ab,ti 
1 AND 2 
Scopus ( TITLE-ABS-KEY ( phosphopyruvate  hydratase )  OR  TITLE-ABS-KEY ( enolase )  
OR  TITLE-ABS-KEY ( beta-enolase )  OR  TITLE-ABS-KEY ( nervous  system-spe-
cific  enolase )  OR  TITLE-ABS-KEY ( neuron-specific  enolase )  OR  TITLE-ABS-
KEY ( neuron  specific  enolase ) )  17,639 document results  
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( TITLE-ABS-KEY ( brain  injury )  OR  TITLE-ABS-KEY ( head  injury )  OR  TITLE-
ABS-KEY ( post-concussive  encephalopathy )  OR  TITLE-ABS-KEY ( brain  contu-
sion )  OR  TITLE-ABS-KEY ( focal  brain  injury )  OR  TITLE-ABS-KEY ( traumatic  
brain  injury )  OR  TITLE-ABS-KEY ( brain  trauma )  OR  TITLE-ABS-KEY ( post  
traumatic  encephalopathy ) ) 
#1 AND #2 
 
Selection criteria 
In the present study, observational studies 
on assessing NSE protein level in children 
(under 18) with TBI were entered. Inclusion 
criteria were identification of traumatic brain 
injury with well-validated diagnostic criteria, 
measurement of serum NSE level during 24 
hours after trauma, assessment of the outcome 
of brain injury based on CT scan, Magnetic 
resonance imaging (MRI) or Glasgow out-
come scale (GOS) (McMillan et al., 2016), 
consisting of a group with favorable and a 
group with unfavorable outcome, reporting 
mean serum NSE level and its standard devi-
ation (derived from the article or contacting 
the authors) or performance characteristics of 
NSE in prediction of TBI related outcome. 
Animal studies and studies lacking two 
groups of patients with and without lesions 
were excluded from the study. All retrospec-
tive and prospective studies were included in 
the study. 
 
Quality assessment and data extraction 
The method of data extraction has been 
precisely reported in previous studies done by 
authors of the present study (Ebrahimi et al., 
2014; Ghelichkhani et al., 2016; Hassan-
zadeh‐Rad et al., 2016; Hosseini et al., 2015a, 
b, 2016; Izadi et al., 2016a, b; Nakhjavan-
Shahraki et al., 2017; Rahimi-Movaghar et 
al., 2016; Safari et al., 2016; Yousefifard et 
al., 2016a-d). In summary, search results were 
combined and same references were excluded 
using EndNote (version X5, Thomson Reu-
ters, 2011). Title and summary of extracted 
articles were assessed by two independent re-
searchers and were entered in a predesigned 
form. Results of the systematic search of the 
present study were depicted by a flow chart 
which was designed based on PRISMA state-
ment instructions (Moher et al., 2009). Ex-
tracted data consisted of data regarding study 
design, patient characteristics (age, sex, se-
verity of trauma), method of measuring NSE 
level, its storage temperature, assessed out-
comes, sample size of the studies, mean, 
standard deviation, sensitivity, specificity of 
NSE in identification of brain lesions, final di-
agnosis of patients with traumatic brain injury 
and cut off point of NSE level. In case of in-
accessibility to authors, estimation methods 
were used to calculate mean and standard de-
viation from median and range of data 
(Higgins and Green, 2011; Hozo et al., 2005). 
If results were reported in charts, data were 
extracted from these charts using the method 
introduced by Sistrom and Mergo (2000). 
Quality of studies was assessed using sug-
gested instructions in quality assessment of 
studies of diagnostic accuracy included in 
systematic reviews version 2 (QUADAS-2) 
(Whiting et al., 2011). 
 
Statistical analysis 
Data analysis was done using STATA 
version 11.0 (Stata Corporation, College Sta-
tion, TX). Patients were categorized into two 
groups of good outcome (Full recovery or 
mild disability) and unfavorable outcome 
(moderate to severe disability and death). All 
studies were categorized and summarized 
based on mean value and standard deviation. 
As studies had used different methods for 
measuring NSE level, standardized mean dif-
ference (SMD) was used in the analyses as ef-
fect size using Hedges’ g calculations. Heter-
ogeneity between studies was assessed using 
I2 test with I2 more than 75 percent or a p value 
of less than 0.1 (indicating heterogeneity be-
tween studies). The meta-analysis was done 
using fixed effect model if studies were ho-
mogenous, otherwise a random effect model 
was used. In the present study, subgroup and 
sensitivity analyses were done in order to re-
duce heterogeneity. Funnel plot and Egger’s 
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test were used in order to identify publication 
bias (Egger et al., 1997). In addition, sum-
mary receiver operator characteristic (SROC) 
curve, sensitivity, specificity, positive and 
negative likelihood ratio and diagnostic odds 
ratio of neuron specific enolase in prediction 
of TBI related outcome were calculated to as-
sess the performance of NSE. 
 
RESULTS 
Characteristic of included studies 
Primary search in databases resulted in 
finding of 2006 articles of which repetitive ar-
ticles were omitted resulting in a total of 1685 
studies. After primary screening, full texts of 
63 articles were read and 10 studies were in-
cluded in the meta-analysis (Bandyopadhyay 
et al., 2005; Berger et al., 2002, 2005; 
Chiaretti et al., 2009; Fridriksson et al., 2000; 
Geyer et al., 2009; Lo et al., 2010; Shore et 
al., 2007; Varma et al., 2003; Žurek and 
Fedora, 2012). A flow chart of included stud-
ies is depicted in Figure 1. These studies con-
tained 721 children (mean age of 6.9+1.9, 
58.5 percent boys). According to definitions 
in studies, 343 children (48.2 %) were in the 
group of good outcome and 373 children 
(52.5 %) were in the group of unfavorable 
outcome. In one study (Žurek and Fedora, 
2012), the value of NSE level in prediction of 
two outcomes (mortality and poor neurologi-
cal outcome) was assessed. Therefore, two 
separate experiments were extracted from the 
mentioned study. At the end, data from 11 ex-
periments were entered in the meta-analysis. 
7 experiments (63.6 %) had assessed serum 
NSE level (Bandyopadhyay et al., 2005; 
Berger et al., 2005; Chiaretti et al., 2009; 
Fridriksson et al., 2000; Geyer et al., 2009; Lo 
et al., 2010; Žurek and Fedora, 2012) while 4 
experiments (36.4 %) had assessed CSF level 
of this biomarker (Berger et al., 2002; 
Chiaretti et al., 2009; Shore et al., 2007; 
Varma et al., 2003). Characteristics of in-
cluded studies are shown in Table 2.
 
 
Figure 1: Flowchart of included studies
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Table 2: Summery of included studies’ characteristics 
Author Design Outcome Severity Collec-
tion Time 
Loca-
tion 
Blind
ing 
Sampling 
method 
Stor-
age 
Assay Age
1 
Boy
s2 
Sam-
ple 
size 
Cut off 
(ng/ml) 
Bandyopadhyay et 
al., 2005 
Retro-
spective 
GOS Mild to 
severe 
24 Serum Yes Consecutive 70 Radio- 
immunoassay 
8.2 67 86 21.2 
Berger et al., 2002 Retro-
spective 
GOS Severe 24 CSF NR Consecutive 70 ELISA 0.2-
9 
NR 10 --- 
Berger et al., 2005 Prospec-
tive 
CT scan Mild to 
severe 
24 Serum Yes Convenience 70 ELISA 3.7 78 164 11.36 
Chiaretti et al., 2009 Prospec-
tive 
GOS Severe 6 CSF NR Consecutive 70 NR 7.6 17 32 --- 
Fridriksson et al., 
2000 
Prospec-
tive 
CT scan Mild to 
severe 
24 Serum Yes Consecutive 70 Radio- 
immunoassay 
8.3 27 49 15.3 
Geyer et al., 2009 Prospec-
tive 
GOS Mild 6 Serum No NR NR ELISA 5 85 148 --- 
Lo et al., 2010 Prospec-
tive 
GOS Mild to 
severe 
24 Serum NR Consecutive 70 ELISA 8.3 21 28 25.0 
Shore et al., 2007 Prospec-
tive 
GOS Severe 24 CSF Yes Consecutive 70 ELISA 5.9 60 108 --- 
Varma et al., 2003 Prospec-
tive 
Death Severe 24 CSF NR Convenience 70 ELISA 0.2-
15 
23 33 --- 
Zurek and Fedora,
2012 
Prospec-
tive 
Death or  
Neurologi-
cal deficit 
Mild to 
severe 
12 Serum Yes NR NR Immuno- 
luminomet-
rical 
8.75 38 63 --- 
1 mean or range of age (year) 
2 percent of male gender 
CSF: Cerebrospinal fluid; CT scan: Computed tomography scan; ELISA: Enzyme-linked immunosorbent assay; GOS: Glasgow outcome scale; NR: Not reported 
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Quality control 
Studies were controlled based on their 
methodology and they were scored using in-
structions of QUADAS-2. Details of quality 
control of included studies are depicted in 
Figure 2. The assessment of outcome was 
done blindly in only 4 studies. 
 
Meta-analysis 
The value of serum NSE level in prediction 
of outcome of TBI in children 
6 studies including 7 experiments were 
entered in order to assess the value of serum 
NSE level in prediction of outcome of TBI in 
children (Bandyopadhyay et al., 2005; Berger 
et al., 2005; Fridriksson et al., 2000; Geyer et 
al., 2009; Lo et al., 2010; Žurek and Fedora, 
2012).  
Analyses showed a significant heteroge-
neity between studies (I2 = 92.4; p<0.0001). 
However, publication bias was not observed 
(p=0.62). Mean serum NSE level in children 
with TBI related unfavorable outcome was 
significantly higher than levels observed in 
other children (SMD=1.3; 95 % CI: 0.5 to 2.1; 
p=0.001) (Figure 3). 
The source of heterogeneity was sought 
using subgroup analysis. Meta-regression 
showed that differences in assessed outcome 
(OR=3.4; 95 % CI: 1.04-12.6; p=0.03), blind-
ing status (OR=77.3; 95 % CI: 11.6-515.2; 
p=0.002) and patient selection method 
(OR=7.5; 95 % CI: 1.8-31.7; p=0.02) were 
the most important source of heterogeneity 
(Table 3). 
 
 
Figure 2: Risk of bias and applicability concerns of included studies assessing value of neuron specific 
enolase concentrations in prognosis in children with traumatic brain injury 
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Figure 3: Forrest plot of serum neuron specific enolase in prediction of traumatic brain injury in children. 
CI: Confidence interval; SMD: Standardized mean differences 
Table 3: Subgroup analysis of value of serum neuron specific enolase in prediction of pediatric traumatic 
brain injury 
Variable P for publication bias I-squared (p value) Effect size  
(95 % CI) 
P 
Study design     
Retrospective 0.99 0.0 % (>0.99) 1.8 (1.0-2.6) <0.0001 
Prospective 0.74 93.5 % (<0.0001) 1.3 (0.4-2.1) 0.006 
  Between groups significance 0.64 
Assessed  
outcome  
    
GOS 0.73 0.0 % (0.61) 1.5 (1.1-1.9) <0.0001 
Other 0.85 97.3 (<0.0001) 1.2 (-0.4-2.7) 0.14 
  Between groups significance 0.03 
Blinding     
No 0.99 87.1 % (<0.0001) 1.1 (0.1-2.0) 0.02 
Yes 0.73 93.7 % (<0.0001) 1.7 (0.3-3.0) 0.02 
Unclear 0.99 0.0 % (0.99) 1.0 (-0.1-2.1) 0.08 
  Between groups significance 0.002 
Patient selection method    
Consecutive 0.63 64.9 % (0.06) 1.1 (0.3-1.9) 0.007 
Convenience 0.99 0.0 % (0.99) 2.6 (2.2-3.1) <0.0001 
Unclear 0.03 87.1 % (<0.0001) 1.1 (0.1-2.0) 0.02 
  Between groups significance 0.02 
Assay method     
ELISA 0.87 97.2 % (<0.0001) 1.3 (-0.4-3.1) 0.14 
Other 0.07 63.6 % (0.04) 1.3 (0.7-1.9) <0.0001 
  Between groups significance 0.95 
Sample size     
< 30 0.99 0.0 % (0.99) 1.0 (-0.1-2.1) 0.08 
≥ 30 0.66 93.7 % (<0.0001) 1.4 (0.5-2.6) 0.002 
  Between groups significance 0.08 
Between groups significance were calculated based on meta-regression analysis. Bold values depicted significant difference 
between subgroups. CI: Confidence interval
NOTE:	Weights	are	from	random	effects	analysis
Overall		(I‐squared	=	92.4%,	p	=	0.000)
Zurek
Zurek
Berger
Geyer
Fridriksson
Author
Bandyopadhyay
Lo
2012
2012
2005
2009
2000
Year
2005
2010
1.33	(0.53,	2.13)
1.34	(0.70,	1.98)
1.68	(0.92,	2.45)
2.63	(2.21,	3.06)
0.30	(‐0.04,	0.64)
0.58	(0.00,	1.15)
SMD	(95%	CI)
1.80	(0.98,	2.61)
0.98	(‐0.11,	2.07)
	 	0‐3.06 3.06
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The value of CSF level of NSE in prediction 
of the outcome of TBI in children 
In literature review, only 4 studies had as-
sessed the value of CSF level of NSE in pre-
dicting the outcome of TBI in children 
(Berger et al., 2002; Chiaretti et al., 2009; 
Shore et al., 2007; Varma et al., 2003). A sig-
nificant heterogeneity was also observed 
among these studies (I2 =87.2 %; p<0.001). 
Publication bias was not observed (p=0.12). 
The findings show that mean CSF level of 
NSE in children with TBI related unfavorable 
outcome is significantly higher than levels ob-
served in children with good outcome 
(SMD=2.45; 95 % CI: 1.04 to 3.8; p<0.0001) 
(Figure 4). A subgroup analysis could not be 
done due to the small number of studies in this 
section. 
Performance of NSE in prediction of  
pediatric TBI 
Screening performance characteristics of 
NSE in prediction of pediatric TBI related 
outcome was done in 4 studies 
(Bandyopadhyay et al., 2005; Fridriksson et 
al., 2000; Geyer et al., 2009; Žurek and 
Fedora, 2012). All these studies focused on 
serum levels of NSE. Cut offs of NSE were 
varied between 11.36 to 25.5 ng/ml (Table 2). 
SROC, sensitivity and specificity of serum 
NSE level in prediction of TBI related out-
come were 0.75 (95 % CI: 0.72 to 0.79), 0.74 
(95 % CI: 0.64 to 0.82) and 0.69 (95 % CI: 
0.59 to 0.77), respectively. Positive likelihood 
ratio, negative likelihood ratio and diagnostic 
odds ratio of serum NSE level were 2.4 (95 % 
CI: 1.7 to 3.3), 0.38 (95 % CI: 0.26 to 0.55) 
and 6.0 (95 % CI: 3.0 to 12.0), respectively 
(Figure 5). 
 
 
Figure 5: Summary receiver operator character-
istic (SROC) curve of neuron specific enolase in 
prediction of pediatric traumatic brain injury. AUC: 
Area under the curve 
  
Figure 4: Forrest plot of cerebrospinal fluid neuron specific enolase in prediction of traumatic brain in-
jury in children. CI: Confidence interval; SMD: Standardized mean differences 
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DISCUSSION 
The present meta-analysis assessed the di-
agnostic value of NSE in children with TBI. 
The findings show that both serum and CSF 
levels of NSE are higher in children with un-
favorable outcome. However, area under the 
curve of NSE indicates moderate perfor-
mance of this biomarker in prediction of out-
come in children with TBI. 
In comparison with other studies, Daoud 
et al. (2014) reported a strong association be-
tween NSE level and unfavorable outcome in 
children with TBI in a systematic review in 
2013 consisting of 3 studies (Daoud et al., 
2014). Kochanek et al. (2013) also reported 
similar findings in a narrative review. In addi-
tion, Menascu et al. (2010) considered NSE as 
a probable biomarker of prediction of out-
come in children with TBI. In a meta-analysis 
by Cheng et al. (2014) NSE level had direct 
relationship with mortality and unfavorable 
outcome in adults with TBI. However, dis-
criminatory power of NSE in prediction of 
mortality and neurologic outcome was mod-
erate. Mercier et al. (2012) showed that there 
is a meaningful relationship between NSE 
level and outcome in adults with TBI alt-
hough, optimal clinical threshold of this bi-
omarker in prediction of outcome of TBI has 
not been identified yet. Finding of these two 
meta-analyses are consistent with findings of 
the present study. 
The present study showed that both serum 
and CSF level of NSE have direct relationship 
with unfavorable outcome in children with 
TBI. However, there was a significant hetero-
geneity among studies. Differences in as-
sessed outcome, blinding status and patient 
selection method were the most important 
sources of heterogeneity in assessing the 
value of serum NSE level. Performance of se-
rum NSE level in prediction of unfavorable 
outcome was in a moderate level. This can be 
due to the fact that brain is not the only source 
of NSE and it can also be found in platelets 
and red blood cells (Elson and Ward, 1994). 
In addition, trauma to other organs can lead to 
elevations in serum levels of this biomarker. 
Therefore CSF level of NSE could be a more 
accurate predictor of severity of brain injury. 
However, there is no study assessing the per-
formance characteristics of CSF concentra-
tion of NSE in prediction of outcome in chil-
dren with TBI. In addition, a lumbar puncture 
is needed in order to obtain CSF level of NSE 
and such invasive procedures come with ethi-
cal limitations in all children with TBI. 
Subgroup analysis showed that NSE has 
different values in predicting TBI, depending 
on the outcome under assessment. The reason 
of this finding might be the severity of injury. 
Glasgow outcome scale (GOS) is a scale con-
sisting of six categories of good recovery, 
mild disability, moderate disability, severe 
disability, persistent vegetative state and 
death (McMillan et al., 2016). Most studies 
have divided GOS to two groups of poor out-
come (severe disability, persistent vegetative 
state and death) and good outcome (good re-
covery, mild disability and moderate disabil-
ity) and then have assessed the value of NSE 
in predicting the mentioned outcomes. It 
seems that NSE level rises dramatically in 
poor outcome patients and subsequently this 
increases the predictive value of NSE. 
Blinding status of the observer is another 
influential factor on the value of NSE. Studies 
analyzing data in a blind manner have re-
ported greater values for NSE. This indicates 
the importance of blinding status of observers 
in designing the methodology in order to get 
more accurate and more reliable results 
(Hróbjartsson et al., 2014).  
In addition, different sampling methods 
alter the results regarding the value of NSE. 
Studies using convenience sampling have re-
ported a greater value for NSE in prediction 
of the outcome of TBI in children. This might 
be due to the possible selection bias present in 
the convenience sampling (Hedt and Pagano, 
2011). However, NSE was capable of predict-
ing the outcome of TBI when consecutive 
sampling was used. Hence, selection bias did 
not have a significant effect on final interpre-
tation of the results in the present meta-anal-
ysis. 
Although an extensive search was done in 
databases to find maximum number of related 
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articles, only 10 studies were included in the 
present meta-analysis with most recent one 
published in 2012. In order to find more re-
cent articles a hand-search was done in 
Google Scholar, Google motor engine, Trip 
database, ProQuest database and bibliography 
of relevant studies. Only one study in 2016 
was found (Wilkinson et al., 2016) in which 
needed data were not presented in the article. 
Corresponding author and other authors of the 
mentioned study were contacted by email in 
order to get the needed data however; there 
was no response after two email contacts. In 
general, it seems that there is less attention to 
the value of NSE level in children with TBI 
although, there is still a wide gap in this field 
of study. Inability to find an optimal cut point 
for NSE was one of the limitations of the pre-
sent study. Additionally, small number of 
studies assessing CSF level of this biomarker 
lead to a significant heterogeneity among in-
cluded studies that made the source of heter-
ogeneity less obvious. 
 
CONCLUSION 
Finding a reliable biomarker in prediction 
of the outcome of TBI in children can be use-
ful in management of these patients. In the 
present study, the value of NSE level in pre-
diction of the outcome of TBI in children was 
assessed in a meta-analytical approach. The 
findings indicate that the performance of NSE 
level in prediction of unfavorable outcome in 
children with TBI is in a moderate level. 
However, lack of sufficient number of studies 
is felt in this aspect and further research is 
need. 
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